温和和慢性病毒竞争抑制噬菌体-抗生素协同作用
Phage-antibiotic synergy inhibited by temperate and chronic virus competition
摘要:
随着抗生素耐药性在常见细菌感染中越来越频繁,替代治疗策略如噬菌体疗法在医学领域得到了更广泛的研究。虽然许多研究已经探索了抗生素、噬菌体疗法或抗生素与抗生素的协同组合的功效,但尚未考虑病毒竞争对抗生素治疗功效的影响。在这里,我们模拟抗生素和两种病毒类型,温和和慢性,在控制细菌感染之间的协同作用。我们证明,虽然抗生素和温带病毒的组合表现出协同作用,温带和慢性病毒之间的竞争抑制抗生素的细菌控制。事实上,我们的模型表明,当大部分细菌产生抗生素耐药性时,抗生素治疗可能会违反直觉地增加细菌负荷。
英文摘要:
As antibiotic resistance grows more frequent for common bacterial infections, alternative treatment strategies such as phage therapy have become more widely studied in the medical field. While many studies have explored the efficacy of antibiotics, phage therapy, or synergistic combinations of phages and antibiotics, the impact of virus competition on the efficacy of antibiotic treatment has not yet been considered. Here, we model the synergy between antibiotics and two viral types, temperate and chronic, in controlling bacterial infections. We demonstrate that while combinations of antibiotic and temperate viruses exhibit synergy, competition between temperate and chronic viruses inhibits bacterial control with antibiotics. In fact, our model reveals that antibiotic treatment may counterintuitively increase the bacterial load when a large fraction of the bacteria develop antibiotic-resistance.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。